Geron | GERN - Ebitda

Stock Price
1.69
Daily Change
0.11 6.65%
Monthly
-6.39%
Yearly
-3.16%
Q1 Forecast
1.53

Geron reported $-9.47M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Amgen USD 5.14B 775M Dec/2025
Bio Techne USD 103.42M 7.47M Dec/2025
Cassava Sciences USD -11.73M 33.44M Sep/2025
Cytokinetics USD -277.18M 169.36M Sep/2025
Esperion Therapeutics USD -27.51M 9.5M Sep/2023
Exelixis USD 248.93M 28.02M Sep/2025
Genmab DKK 477M 101M Sep/2025
Geron USD -9.47M 1.92M Sep/2025
Gilead Sciences USD 4.03B 628M Sep/2025
Incyte USD 414.5M 92.42M Dec/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Novartis USD 5.88B 290M Sep/2025
Novavax USD -117.12M 55.66M Sep/2024